Connecting you to content on EBSCOhost

Works by Itano, Yuya

Results: 4

1

High urinary glucose is associated with improved renal prognosis in patients with diabetes mellitus.

Published in:

Journal of Diabetes Investigation, 2021, v. 12, n. 6, p. 998, doi. 10.1111/jdi.13428

By:

Itano, Yuya;
Sobajima, Hiroshi;
Ohashi, Norimi;
Shibata, Taiga;
Fujiya, Atsushi;
Nagata, Takanobu;
Ando, Masahiko;
Imaizumi, Takahiro;
Kubo, Yoko;
Ozeki, Takaya;
Katsuno, Takayuki;
Kato, Sawako;
Yasuda, Yoshinari;
Maruyama, Shoichi

Publication type:

Article

2

A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020.

Published in:

Clinical & Experimental Nephrology, 2021, v. 25, n. 12, p. 1277, doi. 10.1007/s10157-021-02098-5

By:

Wada, Takehiko;
Ishimoto, Takuji;
Nakaya, Izaya;
Kawaguchi, Takehiko;
Sofue, Tadashi;
Shimizu, Sayaka;
Kurita, Noriaki;
Sasaki, Sho;
Nishiwaki, Hiroki;
Koizumi, Masahiro;
Saito, Shoji;
Nishibori, Nobuhiro;
Oe, Yuji;
Yoshida, Mai;
Miyaoka, Yoshitaka;
Akiyama, Shin'ichi;
Itano, Yuya;
Okazaki, Masaki;
Ozeki, Takaya;
Ichikawa, Daisuke

Publication type:

Article

3

Impact of etelcalcetide on fibroblast growth factor‐23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis.

Published in:

Nephrology, 2022, v. 27, n. 9, p. 763, doi. 10.1111/nep.14081

By:

Hashimoto, Yusaku;
Kato, Sawako;
Kuro‐o, Makoto;
Miura, Yutaka;
Itano, Yuya;
Ando, Masahiko;
Kuwatsuka, Yachiyo;
Maruyama, Shoichi

Publication type:

Article

4

Rationale and study design of a randomized controlled trial for development of a treatment strategy for chronic kidney disease–mineral and bone disorder by multilateral mechanism of etelcalcetide hydrochloride (the DUET study).

Published in:

Renal Replacement Therapy, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s41100-019-0236-5

By:

Kato, Sawako;
Tsuboi, Masato;
Ando, Masahiko;
Itano, Yuya;
Maruyama, Shoichi

Publication type:

Article